Balyasny Asset Management’s Neurocrine Biosciences NBIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-179,221
Closed -$19.8M 2308
2025
Q1
$19.8M Sell
179,221
-15,507
-8% -$1.72M 0.03% 449
2024
Q4
$26.6M Buy
+194,728
New +$26.6M 0.04% 415
2024
Q2
Sell
-16,684
Closed -$2.3M 2250
2024
Q1
$2.3M Sell
16,684
-203,142
-92% -$28M ﹤0.01% 1057
2023
Q4
$29M Sell
219,826
-258,262
-54% -$34M 0.05% 347
2023
Q3
$53.8M Sell
478,088
-296,976
-38% -$33.4M 0.11% 194
2023
Q2
$73.1M Buy
+775,064
New +$73.1M 0.16% 128
2022
Q1
Sell
-321,388
Closed -$27.4M 2356
2021
Q4
$27.4M Buy
321,388
+162,064
+102% +$13.8M 0.09% 246
2021
Q3
$15.3M Buy
+159,324
New +$15.3M 0.06% 358
2020
Q3
Sell
-2,856
Closed -$348K 1250
2020
Q2
$348K Buy
+2,856
New +$348K ﹤0.01% 804
2019
Q4
Sell
-102,759
Closed -$9.26M 1238
2019
Q3
$9.26M Buy
+102,759
New +$9.26M 0.06% 375
2019
Q2
Sell
-99,366
Closed -$8.75M 1478
2019
Q1
$8.75M Buy
+99,366
New +$8.75M 0.06% 379
2018
Q4
Sell
-163,917
Closed -$20.2M 1471
2018
Q3
$20.2M Sell
163,917
-53,965
-25% -$6.64M 0.09% 266
2018
Q2
$21.4M Sell
217,882
-15,934
-7% -$1.57M 0.1% 260
2018
Q1
$19.4M Sell
233,816
-128,233
-35% -$10.6M 0.08% 296
2017
Q4
$28.1M Sell
362,049
-240,633
-40% -$18.7M 0.09% 279
2017
Q3
$36.9M Buy
+602,682
New +$36.9M 0.14% 170
2017
Q2
Sell
-13,856
Closed -$600K 1411
2017
Q1
$600K Buy
+13,856
New +$600K ﹤0.01% 1082
2016
Q4
Sell
-62,493
Closed -$3.17M 1240
2016
Q3
$3.17M Buy
+62,493
New +$3.17M 0.02% 565
2016
Q1
Sell
-96,250
Closed -$5.45M 1227
2015
Q4
$5.45M Sell
96,250
-109,047
-53% -$6.17M 0.04% 423
2015
Q3
$8.17M Buy
205,297
+145,297
+242% +$5.78M 0.06% 342
2015
Q2
$2.87M Buy
+60,000
New +$2.87M 0.02% 501